The Novalung 1.3m2 gas exchange device made of polymethylpentene (PMP) fibers was evaluated in healthy sheep (35-42kg) in order to characterize its performance and potential use in clinical ECLS. Five Novalung PMP devices were compared to 5 Kolobow silicone rubber devices (1.5m2) that were run on veno-venous ECLS for 72 hours. The two device groups were compared for differences in gas exchange, device pressure gradient, hematology, blood biochemistry and pathology. The results showed superiority in the PMP devices in both oxygen and CO2 exchange when compared at similar blood flow rates. Platelet consumption and pressure gradient were significantly less when using the PMP device. The pressure gradient across the PMP devices was
MASS TRANSFER MODEL FOR THE DESIGNING OF INTRAVASCU-LAR OXYGENATOR DEVICE
Gi-Beum Kim, 1 Seong-Jong Kim, 2 Tae-Kyu Kwon, 1 Chul-Un Hong, 1 Nam-Gyun Kim. 1 1 Division of Bionics and Bioinformatics, College of Engineering, Chonbuk National University, Chonju, Chonbuk, Korea; 2 Dept. of Environmental Engineering & Chemical Technology, Iksan National Collage, Iksan, Chonbuk, Korea. The purpose of this work was considered a simulator to manufacture the artificial lung assist device, and the use of a mathematical model to predict a behavior of blood. We tried to formularize prediction equations to predict the gas transfer rate and pressure drop in order to design an intravenous artificial lung assist device. Designing parameters to predict the effect of the gas transfer rate and pressure drop of modules under various conditions were studied through experimental modeling before inserting the artificial lung assist device into the vein. This simulation was carried out according to the Montecarno's simulation method, and a fourth order Runge-Kutta method was used to solve the equation. As the results, we could estimate the gas transfer rate as a function of the hydraulic diameter of device. The gas transfer rate obtained from the experiment was similar to that predicting by the equation, confirming the usefulness of the equation. We were also able to, estimate the pressure drop as a function of the frontal area of device. The pressure drop obtained from the experiment was similar to that from the equation, again confirming the equations usefulness. We could estimate the gas transfer rate, and the pressure drop of the artificial lung assist device as a function of the frontal area of device. Therefore, these functions are very useful for predicting the gas transfer rate and the pressure drop of the artificial lung assist device. These results may be used to further optimize the design of the artificial lung assist device.
EXPERIMENTAL STUDY OF REGENERATION OF CANINE TRACHEAL CARTILAGE USING SLOW RELEASE OF BASIC FIBROBLAST GROWTH FACTOR(B-FGF) FROM A GELATIN SPONGE
Hitoshi Igai, 1 Noriyuki Misaki, 1 Masashi Gotoh, 1 Yasumichi Yamamoto, 1 Hiroyasu Yokomise. 1 1 Second Department of Surgery, Kagawa University, Miki, Kagawa, Japan. OBJECTIVES We investigated the efficiency of b-FGF released from a gelatin sponge for the regeneration of tracheal cartilage. METHODS A 1-cm gap was made in the mid-ventral portion of each of 10 consecutive cervical tracheal cartilages from the 4th to the 13th ring in 5 experimental dogs. Then a gelatin sponge containing 100 mg of b-FGF solution was implanted in the resulting gap. We killed and examined two of the 5 dogs at 1 and 3 months after implantation, respectively. RESULTS Endoscopically, the implant site was easily detectable because it lacked the continuity of the cartilage rings. Macroscopically, the tracheal lumen showed slight stenosis. Each tracheal cartilage gap was filled with elastic tissue, which connected the stumps of each cartilage ring. Microscopically, myofibroblasts that were positive for proliferating cell nuclear antigen (PCNA) and were stained with anti-smooth muscle antibody (a-SMA) were increased in the gap, and fibrous cartilage -containing hardly any extracellular matrix but abundant collagen fibers in comparison with hyaline cartilage -showed overgrowth from the perichondrium of the cartilage stumps. Histological findings at the implant site were similar in the two dogs killed at 1 and 3 months. The other three dogs are still surviving without problems more than 3 months after implantation. CONCLUSIONS Slow release of b-FGF from a gelatin sponge is able to induce proliferation of myofibroblasts and regeneration of fibrous cartilage. Our lab is exploring further improvements to our respiratory support catheter while its current version (the Hattler Catheter ®) is undergoing commercialization and readiness for human clinical trials. Our current respiratory support catheter uses a pulsating balloon to enhance O 2 and CO 2 exchange, with pulsation at a constant beat rate and balloon volume. In this study, we tested the hypothesis that using random balloon pulsation rates and volumes could disrupt fluid entrainment within the fiber bundle, improve overall mixing, and increase gas exchange. We compared random pulsation rates and volumes with standard constant pulsation at the average rates and balloon volumes used in random pulsation. Gas exchange of our catheter with 100% O 2 sweep gas was measured in a 3 L/min water flow loop at 37°C. For constant balloon volume, CO 2 gas exchange with random pulsation from 200 -400 beats per minute (BPM) was not significantly different than for constant pulsation using the average beat rate (286 BPM) of the random pulsations: 302.2 Ϯ 1.4 versus 299.5 Ϯ 0.9 ml/min/m 2 . For a constant pulsation rate of 300 BPM, CO 2 gas exchange using random versus constant balloon volume was statistically significant but negligible: 294.3 Ϯ 0.6 versus 301.1 Ϯ 1.7 ml/min/m 2 . Random versus constant rate and volume pulsation also showed a negligible change for O 2 exchange. We conclude that random balloon pulsation of either rates or volumes does not impact overall mixing sufficiently to improve gas exchange in our respiratory catheter.
CAN RANDOM BALLON PULSATION ENHANCE GAS EXCHANGE IN

DEVELOPMENT AND CHRONIC ANIMAL TESTING OF THE NA-TIONAL CARDIOVASCULAR CENTER HEPARINLESS ECMO SYSTEM
Eisuke Tatsumi, 1 Yoshiyuki Taenaka, 1 Nobumasa Katagiri, 1 Toshihide Mizuno, 1 Kei Ota, 1 Tomonori Tsukiya, 1 Yoshiaki Takewa, 1 Akihiko Homma, 1 Masaki Sato, 2 Hidenori Tanaka, 2 Kazunari Sakai, 3 Toshiaki Matsuda. 3 1 Department of Artificial Organs, National Cardiovascular Center Research Institute, Suita, Osaka, Japan; 2 Toyobo Co., Ltd, Ohtsu, Shiga, Japan; 3 Dainippon Ink and Chemicals Inc., Tokyo, Japan. A heparinless ECMO system has been developed at the National Cardiovascular Center of Japan. The system consists of a leakless oxygenator, and a sealless durable centrifugal pump. The oxygenator is made of special hollow fiber membrane in which micropores are blindended at the blood-contacting surface to prevent plasma leakage. Membrane area and priming volume are: 0.4 m2 and 45 ml in S-type, 0.8 m2 and 95 ml in M-type, and 1.3 m2 and 130 ml in L-type, respectively. The entire blood-contacting surface is coated with a novel heparin-bonded material that imparts extremely potent antithrombogenicity. Heparinless veno-arterial bypass ECMO was carried out in chronic animal experiments using 15 goats (2 for S-type, 3 for M-type, and 10 for L-type). Systemic anticoagulation was not conducted at all. In all animals, heparinless ECMO could be run for more than one month (up to 3 months) until elective termination. Gas-exchange function was maintained stably during the experiments. Platelet count, ACT, APTT, and fibrinogen were kept normal, and the blood heparin level was always less than measurable level. In postmortem examination, some clotting was observed at the marginal area of the inlet and outlet of oxygenator, but the fiber bundle was always surprisingly clean. In conclusion, our ECMO system has an ability to be used for long-term support with minimal or no systemic heparinization. CFD was applied to the design of the inlet/outlet of a thoracic artificial lung (TAL). Simulations were performed in three-dimensional geometries to optimize the TAL design based on flow patterns and resistance. Three types of inlet/outlet expansions and contractions were examined: abrupt, angled, or contoured angle model. In the abrupt model, inlet/outlet diameters of 1/2", 5/8", and 3/4" were investigated. For the angled model, angles of 15°, 30°, 45°, 60°, and 75°were studied. The contoured angle is a smoother version of the angled model. Navier-Stokes equations were calculated using FLUENT and the k-⑀ model to simulate turbulent flow for Reynolds numbers of more than 2300. Visualizations of velocity vectors and streamlines indicate that a large ring-like recirculation zone exists in the abrupt model and, to a lesser extent, in the angled model. The recirculation creates energy losses following increase in resistance. No recirculation behind the expansion was found in the contoured angle model. Resistance, in general, increases linearly with flow rate, decreases inversely with inlet/outlet diameter, and decreases with increase in angle. The contoured angle model has the smallest resistance: approximately 0.4 mmHg/(L/min) at 8 L/min, compared to 0.64 and 0.51 mmHg/(L/min) for the abrupt and 75°angle models, respectively. Therefore, the optimized model requires a contoured geometry with larger angle and inlet/outlet diameter. These preliminary results imply that CFD provides useful information about hemodynamic optimization of the TAL before the device is made and tested in-vitro.
CFD ANALYSIS OF ANASTOMOSIS RESISTANCE TO ENSURE NOR-MAL RV FUNCTION
Jeongho Kim, 1,2 Keith E Cook. 1,2 1 Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI; 2 Department of Surgery, University of Michigan, Ann Arbor, MI.
High pulmonary system resistance can lead to RV dysfunction during thoracic artificial lung (TAL) attachment. This study analyzes the flow patterns and resistance at pulmonary artery anastomoses during simulated in-series TAL attachment. The hemodynamic changes were investigated with three parameters: the steady, inlet flow rate (Q inlet ), anastomotic angle (␣), and the percentage of the inlet flow going through the anastomoses, ⌽. The Q inlet was given as 2, 4, 8, 12, 16 , and 20 L/min. The angles, ␣, were equal to 90°, 60°, and 45°. The % of inlet flow to the anastomoses are 0%, 25%, 50%, 75%, and 100% of Q inlet . The 90°a ngle indicates that the graft is attached perpendicular to the PA. It is assumed that the % of flow is created by banding the PA between the anastomoses. Three-dimensional simulations were performed using computational fluid dynamics. Result shows that four possible recirculation zones were observed: near the entrance of the upstream wall of the proximal graft, both upstream and downstream to the PA occlusion, and at the toe near the distal anastomosis. Results indicate that when PA banding is increased, resistance increases linearly in both proximal and distal anastomoses. Resistance also increases linearly with flow rate, and decreases with anastomotic angle. Therefore, a minimal anastomosis angle ␣ is preferable. The 45°proximal anstomosis has a resistance of 0.33 mmHg/(L/min) at 8 L/min, compared to 0.39 and 0.34 mmHg/(L/ min) for the 90°and 60°angles. Therefore, the smaller angle should improve RV function due to lower resistance. These results will be confirmed with in-vitro experiment.
DEVELOPMENT OF A NOVEL INTEGRATED PUMP OXYGENATOR
ZJ Wu, 1 J Zhang, 1 TDC Nolan, 1 SD Chambers, 2 BP Griffith. 1 1 Department of Surgery, University of Maryland Baltimore, Baltimore, MD; 2 MC3, Inc., Ann Arbor, MI.
Currently, available therapies for acute and chronic lung diseases have not been effective and have various problems associated with technologies used. We present a novel efficient active mixing pumplung with the goal of providing total respiratory support to an ambulatory patient. The integrated pump-lung incorporates a centrifugal flow impeller, a fiber membrane bed disposed around the rotating impeller to achieve blood pumping and active mixing for gas exchange, a unique bypass channel to provide a path for blood to be recirculated through the fiber bed multiple times, resulting in increased efficiency and reduced surface area for gas exchange. A series of studies, including computational simulation and experimental bench testing, have been performed to implement this concept into a viable artificial lung device. The computational fluid dynamics (CFD) simulated and in-vitro experimental results, from an initial prototype model with a surface area of 0.45m 2 , indicate that APL can deliver a promising oxygen transfer rate at ϳ350 ml/min/m 2 at a blood flow rate of 6 liters/min. It outperforms all current commercial available oxygentors. Furthermore, the device can increase the blood pressure to ϳ100 mmHg at the rate of 6 liters/min. Our CFD analysis indicates that the current open vane impeller was not optimized to distribute blood across the fiber bed uniformly, thus suggesting that there is a potential to further increase the gas exchange efficiency by optimizing the impeller and flow path. An implantable artificial lung, the MC3 Biolung ®, was attached to the pulmonary circulation of four male sheep (32.1Ϯ3.6kg) in parallel with the natural lungs for 7 days. The purpose of the study was to determine the long-term effects of attachment on device performance and animal physiology and hematology. After the surgery, the animals were awakened from anesthesia and breathed room air thereafter. Heart rate (HR), mean arterial pressure (P a ), central venous pressure (P cvp ) were monitored continuously, arterial blood gases were obtained every 1 to 4 hours, and platelet counts were taken once a day. A flow probe was placed on the TAL inlet tubing to measure the TAL flow (Q TAL ). After 7 days, the animals were euthanized and necropsied. Hemodynamics remained stable over 7 days in all animals, and the averages were HR ϭ 136Ϯ 6.8 beats/min, Pa ϭ 98.1Ϯ 3.2 mmHg, Pcvp ϭ 8.1Ϯ1.9 mmHg, respectively. Arterial blood gases were maintained in good condition as PO2 ϭ 114Ϯ10 mmHg, PCO2 ϭ 37.7Ϯ1.6 mmHg. The TAL function was also maintained well, average oxygen transfer rate was 113Ϯ15 mL/min. There was no infection in the chest or evidence of embolism in vital organs at necropsy. A few small clots were observed on the TAL housing but the TAL inlet and outlet were clean after 7 days. These results indicate that the TAL is suitable for 7 day attachment.
7-DAY, IN PARALLEL ARTIFICIAL LUNG TESTING IN SHEEP
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ASAIO PULMONARY ABSTRACTS Thoracic Artificial Lung (TALs) may be implanted in parallel under very low blood pressure conditions. Microporous fibers in the TAL, therefore, are more susceptible to risk of gas embolism due to sweep gas leakage across the fiber than bypass oxygenators, and relatively small obstructions in the sweep gas path could cause air emboli. These obstructions include water vapor accumulation in the fibers. The goal of this study was to determine what fiber is most resistant to sweep gas leakage and water accumulation. Three fiber types (Celgard ™ X30 240: CE, Membrana ™ OxyPlus PMP 90/200: ME, silicon coated Celgard ™ : SCE) were incorporated into miniature TALs. The fiber's transmural pressure gradient (⌬P) was varied using an adjustable clamp on the gas outlet tubing. The circuit was run for 5 minutes while leaked gas was trapped and measured for volume, Vg. Accumulated water was collected for 6 hours. Pressure at gas inlet (P g, in ) and outlet (P g, out ) port was obtained and gas path resistance (R g ) was calculated as, R g ϭ (P g,in -P g,out )/(Sweep Gas Flow Rate). Gas leakage was present at ⌬P Ͼ 5 mmHg in all fiber types, but SCE was the most resistant. With ⌬Pϭ20 mmHg, V g was about 20 ml with CE and ME fiber, while, it was only 0.6 ml in SCE fiber. There was no significant difference in accumulated water between fiber types, but R g was highest in the ME fiber. Therefore, the SCE fiber is ideal for the device due to its transmural leak resistance and low gas path resistance. Objective: To assess whether decelerating vs.square flow will delay choke flow during total liquid ventilation with perfluorocarbon. Methods: After establishing airway access in 3 adult New Zealand rabbits(3.5Ϯ0.5 kg), total liquid ventilation initiated in standard square wave flow by instilling 20 ml/kg of preoxygenated perfluorocarbon as FRC and 17.5 ml/kg as tidal volume with RR of 5 cycles/minute(I:E 1:2). Dwell time was introduced at the end of expiration in increments of 250 msec to increase drainage velocity and thus, identify the expiratory time at which choke(Paw T choke).The E T choke at 9 decelerating waveforms were compared to square wave.Waveforms were created by altering the time at plateau velocity (Vp:10%, 33%, 66% or 100% of E T at plateau velocity) and decelerating to 10%, 33%, 66% or 100% of Vp at the end of expiration.VT, FRC and RR were kept constant. Result: E T choke was less for all 9 decelerating scenarios compared to square wave.The best decelerating scenarios reduced the E T choke by Ͼ1second compared to square wave. Conclusion: Decelerating expiratory flow delays choke compared to square wave.Reducing E T choke may allow enhanced gas exchange via introduction of dwell time or increased respiratory rate. Chronic lung disease typically results in elevated pulmonary system resistance (PSR) and can cause right ventricular hypertrophy and dysfunction. Thoracic artificial lungs (TALs) may be used with these patients as a bridge to transplantation. To determine the hemodynamic effects, the MC3 Biolung ® was attached in-parallel, without pulmonary artery banding, in six sheep with induced chronic pulmonary hypertension (HYP) and three healthy sheep (HEA). Hemodynamic data was acquired just prior and 15 min. after commencing TAL flow. Prior to TAL attachment, the PSR of the healthy and hypertensive sheep were 1.18 Ϯ 0.24 and 3.75 Ϯ 1.25 mmHg/(L/min), respectively. After TAL attachment, HEA PSR decreased significantly to 0.77 Ϯ 0.47 (pϭ0.03), and HYP PSR decreased significantly (pϭ0.006) to 1.33 Ϯ 0.48. Prior to TAL attachment, the average HEA and HYP cardiac indices (CIs) were 0.094 Ϯ 0.021 and 0.097 Ϯ 0.015 respectively. After implantation of the TAL, the HEA and HYP CIs were 0.112 Ϯ 0.022 and 0.111 Ϯ 0.019, respectively. Neither group showed a significant difference between pre and post TAL attachment (pϭ0.25 and 0.86). The CIs were in normal ranges for all situations examined, indicating HYP sheep had compensated for elevated PSR. Thus, TAL attachment had little effect on CI. TAL attachment significantly reduced PSR in both groups, however, suggesting that, in chronic lung disease patients, the TAL might reduce RV hypertrophy, and, in more severe disease states, improve RV function. An artificial non-thrombogenic surface can be designed by coating the surface with nitric oxide (NO) donors. This coating is useful on solid surfaces, but is not feasible on gas exchange membranes. We investigated the effects of adding NO across a membrane oxygenator in an attempt to limit platelet activation. Methods: A donor rabbit was used to prepare 400 uCi of 111 In-oxine radiolabeled platelets. A second rabbit was anesthetized, paralyzed, and heparinized prior to carotid-jugular cannulation. The labeled platelets were reinfused, and arteriovenous flow through a custom made 0.5m 2 hollow-fiber oxygenator was initiated. Three groups of rabbits (each nϭ6) were utilized: control, 500ppm NO, and 1000ppm NO. Samples were drawn at baseline, 30, 60, 120, 180, and 240 minutes. Platelet counts, WBC counts, platelet aggregometry, ABG values, methoxyhemoglobin and radioactive platelet deposition levels were monitored. Results: No differences in platelet counts, platelet activity, or radioactive platelet deposition were observed between any of the groups. ( p Ͼ 0.4) Conclusion: Although a NO coating may render a surface non-thrombogenic, our study does not find NO to be efficacious when administered through a membrane oxygenator.
DELAYING CHOKE DURING TOTAL LIQUID VENTILATION USING
HEMODYNAMIC EFFECTS OF IN-PARALLEL ARTIFICIAL LUNG IM-PLANTATION IN HEALTHY AND HYPERTENSIVE SHEEP
NITRIC OXIDE IN THE SWEEP GAS PERFUSING THE ARTIFICIAL LUNG: EFFECTS ON PLATELET ACTIVATION AND CONSUMPTION
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ASAIO PULMONARY ABSTRACTS THE "MUCUS SLURPER" COMBINED WITH PERIODIC TRACHEAL FLUSHING WITH HYDROGEN PEROXIDE Gianluigi Li Bassi, 1 Francesco Curto, 1 Cristal Clark, 1 Lisa Steketee, 1 Theodor Kolobow. 1 1 NHLBI/PCCMB, NIH, Bethesda, MD.
Purpose of the study: To prevent bacterial colonization of the trachea, and formation of biofilm within the endotracheal tube. Materials and methods: We replaced the distal tip of a Hi-Lo Evac, Mallinckrodt ETT (CASS ETT), with a compression-molded hollow vinyl ring that contained 3-4 holes in the dependent part. The suction line in the wall of the CASS ETT was extended and bonded to the hollow ring. Suction was activated every 2 min. We tested our device in sheep, mechanically ventilated for 72 hours. Every 6 hours, we introduced through the ETT and the suction port a solution of H 2 O 2 in saline (varying concentration and time of exposure) to fill the ETT and proximal 2-3 cm of the trachea. Tracheal secretions were sampled for quantitative microbiological analyses. At autopsy, the ETT was cut open, samples of its internal surface were prepared for scanning electron microscopy, and tracheal tissue was sampled for quantitative microbiologic, and histological analyses. Results: A concentration of 0.1M H 2 O 2 and exposure time for 2-10 seconds prevented bacterial tracheal colonization during the first 48 hours. At autopsy, the trachea was colonized in the immediate vicinity of the ETT tip, but not at 3 cm, or beyond. Microscopically there was no tracheal injury related to H 2 O 2 . The ETT appeared clean and no biofilm was detected on its internal surface. Conclusion: In studies lasting 72 h, the "Mucus Slurper" prevented accumulation of mucus on the internal surface of the ETT. Brief washing with dilute H 2 O 2 , every 6 hours prevents tracheal bacterial colonization with no mucosal injury. Aim: During total liquid ventilation (TLV), negative pressure may occur during expiration in the airways due to flow limitation (choke flow), which results in airway collapse. It is important to understand if repeated collapse incurs damage to the airways and lung as part of our effort to optimize the TLV technique. Methods: Adult New Zealand rabbits (nϭ8) were randomly divided into 4 groups and ventilated with different strategies: gas ventilation, TLV with no airway collapse, and TLV with collapse induced in either 25 or 75 sequential breaths by increasing the perfluorocarbon drainage velocity until choke flow occurred. Collapse was induced at the beginning of the experiment that lasted 4 hours. Dynamic airway pressure, gas exchange and blood pressure were monitored every 30 minutes. At the end of the study the lungs were excised and specimens processed for light microscopy. Results: Adequate gas exchange and blood pressure were maintained during the studies. Preliminary histological analysis showed minimal inflammation in the airway and parenchyma. Conclusions: Minimal airway injury appears to occur despite application of a severe flow limitation insult. Although choke flow should be avoided for mechanical reasons, these preliminary data suggest that flow limitation episodes are not injurious to the airways. Aim: Flow limitation (FL) may occur during expiration in total liquid ventilation when the flow rate (Q) reaches a maximum and further increases in driving pressure do not result in an increased Q. The location of FL in perfluorocarbon-filled lungs and the effects of lung volume and Q on it were investigated both by measuring pressure along the airways and by radiographic imaging. Methods: 36 New Zealand rabbits were euthanized and divided into 9 groups; their lungs were filled with perfluorocarbon (PFC) to the randomly selected end-inspiratory lung volume (EILV) of 20, 30, or 40 ml/kg and the volume was drained applying randomly 3 different PFC flow rates (2.5, 5.0, 7.5 ml/s). In 5 of the animals, tantalum dust was insufflated to visualize central airways by a high-resolution fluoroscopy unit. Results: The minimum pressure (P) recorded with a catheter shows that FL occurred in the main bronchi and trachea (Pϭ-80mmHg at the trachea vs Pϭ-2mmHg at 2 cm distal from carina) and its location depended minimally on Q or the EILV. This location of FL is confirmed by the lung images acquired. The airway diameters (D) gradually decrease with time, until FL occurs (mean tracheal D reduction 43%). In airways distal to the collapse, there was not a significant decrease in D (13%). Conclusion: Based on these data we conclude that FL occurs in the trachea and main bronchi and is independent of the expiratory flow rate and EILV.
EFFECT OF REPEATED INDUCED AIRWAY COLLAPSE DURING TO-TAL LIQUID VENTILATION
LOCATION OF FLOW LIMITATION IN LIQUID-FILLED RABBIT LUNGS
THE EFFECT OF BUNDLE POROSITY ON THE PERFORMANCE OF A PUMPING PARACORPOREAL ASSIST LUNG USING A ROTATING FIBER BUNDLE
Robert G Svitek, 1,2 Brian J Frankowski, 1 William J Federspiel. 1,2,3,4 1 McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA; 2 Chemical Engineering, University of Pittsburgh, Pittsburgh, PA; 3 Surgery, University of Pittsburgh, Pittsburgh, PA; 4 Bioengineering, University of Pittsburgh, Pittsburgh, PA. We are developing a compact paracorporeal respiratory assist lung (PRAL) that uses a rotating annular fiber membrane bundle to both enhance gas exchange and pump blood. Our ultimate goal is to achieve significant CO 2 removal (100 -120 ml/min) at relatively low veno-venous blood flowrates (500 -1000 ml/min) without the need for a separate pump. This study examined the effect of fiber bundle porosity on the gas exchange and pumping performance of the PRAL. We fabricated two PRAL devices with bundle porosities of 0.43 and 0.80, but otherwise similar with membrane areas of 0.42 m 2 and 0.50 m 2 respectively. The devices were tested for gas exchange in a flow loop using water as the test fluid at 3 L/min. The PRAL with the higher bundle porosity achieved CO 2 removal at 1500 RPM of 153 ml/min/m 2 compared to only 116 ml/min/m 2 for the PRAL with lower bundle porosity. In bovine blood, the PRAL with the higher bundle porosity at 1500 RPM achieved a CO 2 removal rate of 182 ml/min/m 2 at a blood flowrate of only 750 ml/min. In a separate pump test in water, the fiber bundle with higher porosity generated 67 mmHg compared to only 52 mmHg for the fiber bundle with the lower porosity at 0.75 L/min flow at 1500 RPM with water as the test fluid. The fiber bundle with increased porosity is within 10% of our gas exchange target, and the pumping ability is consistent with generating 750 ml/min blood flow through percutaneous cannula less than 20 Fr. The Hattler Catheter® is an intravenous respiratory assist device that uses a centrally located pulsatile balloon within a hollow fiber bundle to enhance gas exchange by active blood mixing. Flow visualization techniques were used to investigate flow patterns induced by balloon pulsation in this respiratory catheter. We tested the hypothesis that the nonsymmetric inflation and deflation of the balloon leads to nonuniform balloon-generated perfusion of the fiber bundle. The respiratory catheter was placed in a 1" ID rigid test section of an in-vitro test loop (3 L/min DI water). Particle image velocimetry (PIV) was used to map the velocity vector field arising from balloon pulsation at 120 beats/min. in lateral cross-sections of the test vessel. Velocity measurement showed that radial velocity varied between 5 cm/s in the region adjacent to the top and bottom quarters of the fiber bundle and 0 cm/s in the region adjacent to the right and left quarter of fiber bundle. We hypothesized that the nonuniform radial flow caused by nonsymmetrical balloon collapse would lead to different gas exchange in the affected fiber regions. An in-vitro study of local gas exchange was performed by selectively perfusing sweep gas flow (100% helium) to four quarter regions of the fiber bundle. Preliminary results showed 15-45% variation in CO 2 exchange among these regions. The variation was not only attributed to nonuniform radial velocities, but also visual observations of nonuniform fiber motion around the bundle. Quantification of fiber motion, via PIV, will be pursued to analyze the relative velocity. Our lab is pursuing the development of a more compact intravenous respiratory assist catheter. In this study we assessed the potential to increase gas exchange efficiency and hence reduce device size by using a rotating hollow fiber bundle in our respiratory catheter. A bench prototype was constructed of a respiratory catheter with a small fiber bundle (25 French, 0.1 m 2 membrane area) that could be steadily rotated up to 10,000 RPM. The performance of the rotating bundle catheter was characterized in a mock vena cava loop using water as the test fluid. The CO 2 and O 2 exchange rates increased with increasing rate of bundle rotation, but plateaued above 6000 -7000 RPM. The maximum gas exchange rates were 529 Ϯ 4.1 and 263 Ϯ 2.3 ml/min/m 2 for CO 2 and O 2 , respectively, which were over 2-fold greater than achieved in the same test using control respiratory catheters based on our pulsating balloon design. Bench tests using bovine blood indicated that the rotation of the fiber bundle per se does not appear to cause significant red cell hemolysis. On-going work is aimed at 1) reducing the degrees of plateau in gas exchange with increasing rotation rate; and 2) designing an implantable version of the catheter with improved seals and bearings and a mechanism to prevent the fiber bundle from damaging the vena cava. Bioengineering, University of Pittsburgh, Pittsburgh, PA; 3 Battelle Memorial Institute, Columbus, OH; 4 Pharos, LLC, Waltham, MA; 5 Pacific Northwest National Laboratory, Richland, WA. A novel microfluidic capillary structure was developed for use with photocatalytic oxygen generating thin films. The microfluidic element was fabricated by multilayer soft lithography, and consisted of stacked sets of arborizing channels capable in the current form of diffusing O2 into the flowing medium across a silicone membrane. Fluid was brought into intimate contact with the diffusing surface, facilitating rapid oxygenation in the laminar flow regime. Convective gas transport was modeled analytically and oxygen concentration measured in real-time by microfabricated luminescent O2 sensors embedded in the capillary channels. The microfluidic capillary array was iteratively designed according to physiological principles with the aim of minimizing shear stress. Oxygen sensors provided reliable and precise measurement of oxygenation over a range of flow rates. Hemolysis, as indicated by plasma free hemoglobin, varied with microchannel design. In capillary designs refined to eliminate adverse flow conditions, thrombus deposition and channel occlusion were greatly reduced. This study demonstrates two milestones in the development of the photolytic artificial lung: 1) Design, fabrication, and refinement of a viable blood-bearing microcapillary structure. 2) Integration of micro-sensors to monitor blood O2 concentration during physiological flow conditions. Bioengineering, University of Pittsburgh, Pittsburgh, PA; 5 Yale University, New Haven, CT. We are developing artificial alveolar-capillary (AAC) modules for use in next generation biohybrid artificial lungs as an improvement over existing hollow fiber bundle technology. Our approach uses microfabrication and soft-lithography techniques applied to polydimethylsiloxane (PDMS) to create intimate arrays of blood and gas microchannels that approach the microvascular scale of the gas exchange units found in the natural lung. Our AAC modules will be designed to 1) increase the surface area to blood volume ratio and decrease diffusion distances compared to current artificial lungs and 2) allow endothelialization of the blood microchannels to improve biocompatibility and reduce thrombosis. In this study we examined endothelial cell seeding and viability in 3-D prototypes containing blood microchannels. Prototypes were fabricated by molding PDMS around an array of 100 wires (100m in diameter) or by molding PDMS on microfabricated channels and stacking the PDMS layers to form a module. The microfabricated prototypes contained 700 channels (20 m high and 100m wide). The modules were incorporated into a perfusion loop and human umbilical vein endothelial cells were seeded statically and dynamically into fibronectin-modified modules. We found that static seeding was initially more efficient than dynamic seeding (31% vs. 13% reduced using alamar blue assay), but that cell viability decreased over ten days to less than 5% reduced. Future work will focus on additional cell culture studies, incorporating gas pathways, and optimizing the gas exchange characteristics of the AAC modules.
FLOW VISUALIZATION STUDY OF A PULSATING RESPIRATORY AS-SIST CATHETER
THE POTENTIAL USE OF ROTATIONAL FIBER BUNDLES IN RESPIRA-TORY ASSIST CATHETERS
DEVELOPMENT OF A 2D MICROFLUIDIC OXYGENATION DEVICE
DEVELOPMENT OF MICROFABRICATED BIOHYBRID ARTIFICIAL LUNGS
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COMPUTATIONAL FLUID-DYNAMIC ANALYSIS OF FLOW THROUGH ENDOTRACHEAL TUBES DURING TOTAL LIQUID VEN-TILATION
Paola Bagnoli, 2 Enrico Cattaneo, 1 Gianfranco B Fiore, 1 Maria Laura Costantino. 1 1 Bioengineering, Politecnico di Milano, Milan, Italy; 2 Mechanical Engineering, Politecnico di Torino, Turin, Italy. Scope: Knowledge of the fluid-dynamic patterns induced by an endotracheal tube (ETT) is important to better the ventilator-patient matching during Total Liquid Ventilation (TLV). TLV employs liquid perfluorocarbons (PFC) as ventilation fluids, however there are no ETTs specifically designed for TLV and commercial ETTs for gas ventilation are used, at present. Methods: 3D parametric models of 2 different ETTs (with or without side hole) inserted in a rigid model of central airways (trachea, carina and first bronchi) were developed and discretized using GAMBIT 2.0 (Fluent Inc.). The ETT tip was placed at different distance (5, 20, 40 mm) from carinal bifurcation. The RNG k-⑀ turbulent model was used with FLUENT 6.1 (Fluent Inc.); the simulated PFC was FC-77 (3M). Unsteady-state simulations (velocity inlet and pressure outlet boundary conditions) were performed to replicate the inspiratory-expiratory ventilation cycle. Results: The main percentage (ϳ60%) of flow was conveyed to and from the right bronchus due to anatomical reasons. The flow delivered through the side hole was negligible during inspiration, while was 43-57% during expiration, although with negative pressure arising. Tracheal shear stress during inspiration was higher at the right bronchus wall and decreased with tip-carina distance inceasing. These results pointed out a set of key aspects which will help through the design of an ETT with shape and geometry optimized for TLV applications. [Introduction] Total liquid ventilation (TLV) is an effective method to grave respiratory failure. We have developed a TLV system with a single piston cylinder pump. In the last ASAIO meeting, we presented the result of ex-vivo experiment on rabbits. However, these result show that the arterial blood pressure was PO2ϭ258.6 Ϯ 45.8mmHg and PCO2ϭ55.2 Ϯ 4.3mmHg, PCO2 was out of the normal range. It suggests the difficulty in discharging CO2 from blood. The purpose of this study is to develop an oxygenator with optimal design for TLV. In this report, three oxygenators were connected with tubes. Gas inflow methods were in series and in parallel. [Materials and methods] Three oxygenators were connected in series to the PFC inflow. The method of flowing in the O2 gas was in parallel and in series. CO2 gas in PFC was measured in the outflow part of each oxygenator.
DEVELOPMENT OF AN OXYGENATOR FOR TOTAL LIQUID VENTI-LATION
[Results] The exhaust efficiency of CO2 gas of each oxygenators was better, when connected in parallel and the efficiency increased by 18.1%.
[Conclusions] PFC has a low surface tension, a low viscosity and a high density. These characteristics were quite different from those of the blood. Therefore, the optimal shape for the TLV oxygenator is different from the oxygenator for blood use. These results of the experiments suggests that flowing in O2 gas in parallel is effective to increase the removal efficiency of CO2 in PFC. We are making the optimal gas exchange device for TLV with compact and high gas exchange rate (Hollow fiber density is 50 %) by flowing in O2 gas in parallel.
A NEWLY DEVELOPED VENTILATOR PROTOTYPE FOR NEONATAL TOTAL LIQUID VENTILATION
Paola Bagnoli, 1,2 Gianfranco B Fiore, 1 Enrico Cattaneo, 1 Ario Monaco, 3 Fabio Acocella, 3 Roberto Colombi, 4 Maria Laura Costantino. 1 1 Dept. Bioengineering, Politecnico di Milano, Milan, Italy; 2 Dept. Mechanical Engineering, Politecnico di Torino, Turin, Italy; 3 Medical Veterinary Faculty, Università degli Studi, Milano, Italy; 4 Surgical Pathology Service, Macedonio Melloni Hospital, Milan, Italy. Aim: Total liquid ventilation (TLV) seems to give significant advantages when preterm infants are concerned, but requires a dedicated ventilator to process the liquid perfluorocarbons (PFC). A new prototype volume-controlled, pressure-limited ventilator was developed and used for preliminary in vivo animal tests. Methods: The ventilator comprises a stepper-motor actuated double-piston system performing respiratory cycles and an uncoupled refresh circuit to achieve PFC filtration, thermostatting, oxygenation, and CO 2 scavenging. A personal computerbased control system manages the two sub-circuits. The apparatus was tested using FC-77 in preliminary animal experiments on 4 New Zealand Rabbits (test lasting 4 hours) and 4 preterm lambs (gestational age 110Ϯ5 days; test lasting 6 hours). Control animals (nϭ2) were gas ventilated. At the end of each experiment, lungs were excised and processed for light microscopy in order to verify airway and lung parenchyma condition. Results: During TLV, adequate gas exchanges (arterial pO 2 ϭ176 mmHg, pCO 2 ϭ 45 mmHg) and blood pressure were maintained in the rabbits, while good oxygenation (pO 2 ϭ94 mmHg) and moderate hypercapnia (pCO 2 ϭ65 mmHg) were recorded during lamb experiments. Histological analysis showed neither atelectasis nor signs of inflammation in the TLV-ventilated animals.
DEVELOPMENT OF AN IMPLANTABLE OXYGENATOR WITH CROSS FLOW PUMP
Yuichi Asakawa, 1 Akio Funakubo, 1 Kazuyoshi Fukunaga, 1 Ichiro Taga, 1 Tetsuya Higami, 2 Tsuyoshi Kawamura, 3 Yasuhiro Fukui. 1 1 Department of Electronic and Computer Engineering, Tokyo Denki University, Japan; 2 Shimane Medical University, Japan; 3 Hyogo Prefecture Health Promotion Association, Japan.
The resistance of the implantable oxygenator to the right ventricle would become very large and might cause cardiac failure if an implantable oxygenator is connected to PA-LA and blood is circulated without a pump. We developed an integrated implantable pump oxygenator using a Cross Flow Pump (CFP). It is difficult to produce an uniform inflow to the oxygenator with centrifugal pump. The CFP can produce a wide uniform flow to the oxygenator because it has a wide impeller and outlet. An uniform flow is vital to avoid turbulence in the inlet part. Therefore, an implantable oxygenator with CFP can provide anti-thrombogenicity and high gas exchange performance. In this study, we evaluated effects on the oxygenator performance by the uniformity of blood velocity at the hollow fiber membrene part using the CFP. The oxygenator had a hollow fiber density of 40% and a membrane surface area of 1.3m 2 . And two types of oxygenators are used. One oxygenator is the prototype oxygenator, and the other is the improved oxygenator with improved uniformity of blood velocity at the hollow fiber membrane part. The O 2 and the CO 2 gas transfer performance of prototype oxygenator were 200mL/min and 137mL/min (V/Qϭ1) respectively at a blood flow rate of 4L/min. The improved oxygenator indicated 200mL/ min and 157mL/min. CO 2 gas transfer performance of the improved oxygenator was increased by 14.6%. The result of our experiments suggests CFP, that produces a wide uniform flow to the oxygenator is effective to attain the high gas exchange performance.
